LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
LBPH
Delisted
LBPH was delisted on the 29th of November, 2024.
17 hedge funds and large institutions have $71.7M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 10 closing their positions.
Holders
17
Holders Change
-5
Holders Change %
-22.73%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
6
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.51M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$18.6M |
| 3 |
3
BlackRock
New York
|
$164K |
| 4 |
4
Renaissance Technologies
New York
|
$95K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$29K |
Top Sellers
| 1 |
1
Citigroup
New York
|
$0 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
O
3
OrbiMed
New York
|
$1.04M |
| 4 |
4
Millennium Management
New York
|
$497K |
| 5 |
5
Goldman Sachs
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
26
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $0 | 33 | +33 | New |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $0 | 38 | +38 | New |
|